english.prescrire.org > Spotlight > Archives : 2018 > Tripoliponumab: French firm Neuronodev demands withdrawal of marketing authorisation and approves 150 million euros for patients

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2018 : 1 | 30 | 60